Telerehabilitation for patients with idiopathic pulmonary fibrosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of two different telerehabilitation exercise programs for patients diagnosed with idiopathic pulmonary fibrosis (IPF). Participants will be randomly assigned to either the Telerehabilitation Exercise Group, which receives online exercises with a physiotherapist, or the Video Group, which follows a pre-recorded exercise video. Both groups will engage in an 8-week exercise program, with weekly follow-ups to monitor their progress. The goal is to determine which approach is more beneficial for improving patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Being between the ages of 18-75
* Having a diagnosis of IPF disease diagnosed according to the following clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS)
* Presence of dyspnea on exertion
* Stable clinical state at the time of admission without infection or exacerbation in the previous 4 weeks

Exclusion Criteria:

* Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and needing high flow oxygen therapy (˃ 3-4 L \\min).
* A history of effort-related syncope or any comorbidity (such as severe orthopedic or neurological deficits or unstable heart disease) that precludes exercise training.
* Participation in a pulmonary rehabilitation program within the past 12 months.

Where it's running

• Yedikule Chest Disease Hospital
  Istanbul, Zeytinburnu, Turkey (Türkiye) Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Photon-counting CT vs standard HRCT to help diagnose IPF and other ILDs

  This study tests whether photon-counting CT can improve identifying IPF and other ILDs compared with standard HRCT for patients discussed in multidisciplinary teams.

  Recruiting Istituto Clinico Humanitas · Rozzano, Italy · NCT07790614

• Single-dose safety and pharmacokinetics of HW241045 in healthy adults

  This trial will test single ascending doses of HW241045 in healthy adults (18–55) to see if the drug is safe, well tolerated, and how it is processed by the body.

  Recruiting Phase 1 Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Beijing · NCT07448194

• Evaluating SB17170 in patients with idiopathic pulmonary fibrosis

  This study is testing a new drug called SB17170 to see if it can help adults with moderate to severe idiopathic pulmonary fibrosis breathe better over 12 weeks.

  Recruiting at 2 sites Phase 2 SPARK Biopharma · Goyang and 4 other locations · NCT06747923

• Identifying biomarkers for progressive pulmonary fibrosis in lung disease patients

  This study is trying to find early signs that can help predict if adults with certain lung diseases will develop progressive pulmonary fibrosis over the next five years.

  Recruiting Amsterdam UMC, location VUmc · Amsterdam, North Holland · NCT06644144

• Exploring the links between sleep hygiene, muscle loss, and brain function in lung disease

  This study looks at how good or bad sleep affects muscle loss and brain function in people with lung diseases like COPD and IPF.

  Recruiting National Hospital Organization Minami Kyoto Hospital · Jōyō, Kyoto · NCT05193136

• Investigating the link between laryngopharyngeal reflux and idiopathic pulmonary fibrosis

  This study is testing if a new way to measure throat reflux can help doctors understand how it affects people with idiopathic pulmonary fibrosis.

  Recruiting National Jewish Health · Denver, Colorado · NCT03418350

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.